All 55 PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) Holdings
There are 55 PBPH holdings. Top 10 companies weight: 60.55%.
Total Market Cap: $3.42T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (55 stocks) | +15.16% | 27.05 | 18.25 | 0.35 | +17.01% | +18.89% | 0.47 | ||||||||||
1 | LLY | Eli Lilly And Co | 14.58% | $1,065.12 | $970B | Drug Manufacturers - General | Healthcare | +29.14% | 45.43 | 29.85 | 0.18 | N/A | N/A | 71 | +14.08% | $1.22K | +40.67% | 0.71 |
2 | JNJ | Johnson & Johnson | 8.99% | $222.89 | $557B | Drug Manufacturers - General | Healthcare | +11.59% | 20.68 | 19.49 | 3.01 | N/A | N/A | 68 | +13.45% | $253 | +9.09% | 0.01 |
3 | ABBV | Abbvie Inc | 6.11% | $215.41 | $381B | Drug Manufacturers - General | Healthcare | -19.65% | 122.69 | 14.95 | 0.59 | N/A | N/A | 75 | +17.40% | $253 | +18.31% | 0.32 |
4 | MRK | Merck & Co Inc | 4.80% | $115.70 | $297B | Drug Manufacturers - General | Healthcare | +4.39% | 27.45 | 22.78 | 5.59 | N/A | N/A | 69 | +12.13% | $130 | +12.86% | 0.32 |
5 | n/a | Roche Holding Ag Ordinary Shares New | 4.74% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
6 | n/a | Novartis Ag Registered Shares | 4.61% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
7 | AZN:XLON | Astrazeneca Plc | 4.45% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
8 | GILD | Gilead Sciences Inc | 4.28% | $127.57 | $166B | Drug Manufacturers - General | Healthcare | +98.59% | 18.01 | 15.22 | 0.33 | N/A | N/A | N/A | N/A | N/A | +18.23% | N/A |
9 | AMGN | Amgen Inc | 4.18% | $328.26 | $181B | Drug Manufacturers - General | Healthcare | +3.49% | 23.21 | 14.79 | 0.75 | N/A | N/A | 60 | +7.30% | $352 | +10.27% | 0.48 |
10 | PFE | Pfizer Inc | 3.81% | $25.55 | $149B | Drug Manufacturers - General | Healthcare | -6.35% | 12.31 | 8.73 | 0.09 | N/A | N/A | 56 | +14.25% | $29 | -3.24% | 0.40 |
11 | n/a | Novo Nordisk As Class B | 3.67% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
12 | BMY | Bristol-myers Squibb Co | 3.07% | $54.46 | $117B | Drug Manufacturers - General | Healthcare | +5.08% | 13.54 | 9.06 | 183.93 | N/A | N/A | 61 | +15.83% | $63 | +0.55% | 0.26 |
13 | VRTX | Vertex Pharmaceuticals Inc | 2.85% | $425.09 | $111B | Biotechnology | Healthcare | +9.89% | 25.66 | 23.04 | 1.64 | N/A | N/A | 74 | +29.08% | $549 | +15.02% | 0.51 |
14 | n/a | Sanofi Sa | 2.49% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
15 | n/a | Gsk Plc | 2.49% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
16 | REGN | Regeneron Pharmaceuticals Inc | 1.67% | $602.92 | $65B | Biotechnology | Healthcare | +20.31% | 14.98 | 13.39 | 83.17 | N/A | N/A | 72 | +38.21% | $833 | +3.75% | 0.64 |
17 | n/a | Argenx Se | 1.28% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
18 | n/a | Takeda Pharmaceutical Co Ltd | 1.26% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
19 | n/a | Bayer Ag | 1.12% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
20 | n/a | Teva Pharmaceutical Industries Ltd | 1.02% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
21 | ALNY | Alnylam Pharmaceuticals Inc | 1.00% | $286.12 | $39B | Biotechnology | Healthcare | N/A | 124.93 | 31.65 | 0.51 | N/A | N/A | 74 | +55.81% | $446 | +14.20% | 0.82 |
22 | n/a | Csl Ltd | 0.99% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
23 | n/a | Ucb Sa | 0.87% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
24 | ZTS | Zoetis Inc Class A | 0.87% | $76.39 | $33B | Drug Manufacturers - Specialty & Generic | Healthcare | +10.56% | 12.89 | 11.36 | 1.12 | N/A | N/A | 70 | +63.10% | $125 | -14.30% | 0.60 |
25 | n/a | Sandoz Group Ag Registered Shares | 0.86% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
26 | n/a | Otsuka Holdings Co Ltd | 0.78% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
27 | n/a | Chugai Pharmaceutical Co Ltd | 0.76% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
28 | n/a | Daiichi Sankyo Co Ltd | 0.72% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
29 | BIIB | Biogen Inc | 0.72% | $188.83 | $29B | Drug Manufacturers - General | Healthcare | -15.32% | 17.38 | 14.04 | 0.64 | N/A | N/A | 63 | +16.21% | $219 | -7.08% | 0.54 |
30 | NTRA | Natera Inc | 0.69% | $212.73 | $29B | Diagnostics & Research | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 77 | +22.64% | $261 | +17.58% | 1.34 |
31 | n/a | Haleon Plc | 0.66% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
32 | RVMD | Revolution Medicines Inc Ordinary Shares | 0.66% | $151.31 | $31B | Biotechnology | Healthcare | +30.12% | N/A | N/A | N/A | N/A | N/A | 78 | +22.61% | $186 | +38.07% | 1.07 |
33 | UTHR | United Therapeutics Corp | 0.64% | $540.05 | $24B | Drug Manufacturers - Specialty & Generic | Healthcare | +26.56% | 19.28 | 19.88 | 2.05 | N/A | N/A | 71 | +23.18% | $665 | +25.24% | 0.45 |
34 | n/a | Astellas Pharma Inc | 0.62% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
35 | INSM | Insmed Inc | 0.59% | $103.73 | $23B | Biotechnology | Healthcare | +12.24% | N/A | 16.37 | 1.09 | N/A | N/A | 79 | +92.81% | $200 | +32.74% | 0.74 |
36 | ILMN | Illumina Inc | 0.56% | $162.55 | $22B | Diagnostics & Research | Healthcare | -6.57% | 34.97 | 31.15 | 2.63 | N/A | N/A | 58 | -11.52% | $144 | -16.21% | 1.03 |
37 | n/a | Merck Kgaa | 0.50% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
38 | RPRX | Royalty Pharma Plc Class A | 0.50% | $54.01 | $24B | Biotechnology | Healthcare | N/A | 27.50 | 46.08 | 1.27 | N/A | N/A | 75 | +9.70% | $59 | +6.80% | 0.28 |
39 | INCY | Incyte Corp | 0.49% | $92.24 | $20B | Biotechnology | Healthcare | +27.16% | 13.38 | 12.41 | N/A | N/A | N/A | 58 | +17.04% | $108 | +2.16% | 0.62 |
40 | VTRS | Viatris Inc | 0.47% | $15.69 | $19B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 6.41 | 0.14 | N/A | N/A | 61 | +15.11% | $18 | +4.66% | 0.80 |
41 | n/a | Genmab As | 0.42% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
42 | MRNA | Moderna Inc | 0.41% | $45.64 | $19B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 48 | -5.35% | $43 | -25.22% | 1.37 |
43 | NBIX | Neurocrine Biosciences Inc | 0.39% | $154.84 | $16B | Drug Manufacturers - Specialty & Generic | Healthcare | +9.25% | 23.29 | 22.73 | 0.19 | N/A | N/A | 75 | +24.11% | $192 | +10.45% | 0.82 |
44 | ROIV | Roivant Sciences Ltd Ordinary Shares | 0.36% | $28.25 | $21B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +38.19% | $39 | 0.00% | 0.92 |
45 | JAZZ | Jazz Pharmaceuticals Plc | 0.36% | $226.12 | $15B | Biotechnology | Healthcare | N/A | N/A | 12.69 | 0.99 | N/A | N/A | 78 | +11.98% | $253 | +5.45% | 0.73 |
46 | n/a | Shionogi & Co Ltd | 0.34% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
47 | EXEL | Exelixis Inc | 0.32% | $48.54 | $13B | Biotechnology | Healthcare | +72.24% | 15.79 | 15.92 | 0.41 | N/A | N/A | 61 | +2.29% | $50 | +16.95% | 0.55 |
48 | n/a | Roche Holding Ag Bearer Shares | 0.32% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
49 | IONS | Ionis Pharmaceuticals Inc | 0.30% | $72.97 | $13B | Biotechnology | Healthcare | -21.44% | N/A | 90.91 | N/A | N/A | N/A | 78 | +38.30% | $101 | +16.01% | 0.74 |
50 | ELAN | Elanco Animal Health Inc | 0.29% | $23.66 | $12B | Drug Manufacturers - Specialty & Generic | Healthcare | -17.32% | N/A | 18.94 | 4.04 | N/A | N/A | 77 | +25.94% | $30 | -7.54% | 1.31 |
PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) Sector Allocation
HEALTHCARE
65.40%MATERIALS
4.50%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%